Role of IP-10 to Predict Clinical Progression and Response to IL-6 Blockade With Sarilumab in Early COVID-19 Pneumonia. A Subanalysis of the SARICOR Clinical Trial

© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which pe...

Descripción completa

Detalles Bibliográficos
Autores: Trigo-Rodríguez, Marta, Cárcel, Sheila, Navas, Ana, Espíndola-Gómez, Reinaldo, Garrido-Gracia, José Carlos, Esteban-Moreno, M. Ángeles, León-López, Rafael, Martínez Pérez-Crespo, Pedro María, Aguilar Alonso, Eduardo, Vinuesa, David, Romero Palacios, Alberto, Pérez-Camacho, Inés, Gutiérrez-Gutiérrez, Belén, Martínez-Marcos, Francisco Javier, Fernández-Roldán, Concepción, León Jiménez, Eva, Aceituno Caño, Alexandra, Corzo, Juan E., Pérez-Nadales, Elena, Riazzo, Cristina, Fuente, Carmen de la, Jurado, Aurora, Torre-Cisneros, Julián, Merchante, Nicolás
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2023
País:España
Institución:Consejo Superior de Investigaciones Científicas (CSIC)
Repositorio:DIGITAL.CSIC. Repositorio Institucional del CSIC
OAI Identifier:oai:digital.csic.es:10261/353028
Acceso en línea:http://hdl.handle.net/10261/353028
Access Level:acceso abierto
Palabra clave:COVID-19
IL-6
IP-10
SARS-CoV-2
Sarilumab
Tocilizumab
Descripción
Sumario:© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

Similares en LA Referencia